The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review
Open accessAbstract
CANCER IS A METABOLIC DISEASE AND THE SOLUTION OF TWO METABOLIC EQUATIONS: to produce energy with limited resources and to fulfill the biosynthetic needs of proliferating cells. Both equations are solved when glycolysis is uncoupled from oxidative phosphorylation in the tricarboxylic acid cycle, a process known as the glycolytic switch. This review addresses in a comprehensive manner the main molecular events accounting for high-rate glycolysis in cancer. It starts from modulation of the Pasteur Effect allowing short-term adaptation to hypoxia, highlights the key role exerted by the hypoxia-inducible transcription factor HIF-1 in long-term adaptation to hypoxia, and summarizes the current knowledge concerning the necessary involvement of aerobic glycolysis (the Warburg effect) in cancer cell proliferation. Based on the many observations positioning glycolysis as a central player in malignancy, the most advanced anticancer treatments targeting tumor glycolysis are briefly reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“Regulation of HIF-1α expression involves its posttranslational hydroxylation at proline residues 402 and 564 (human sequence) by prolylhydroxylases (PHDs), among which PHD2 is the prominent physiological facilitator of the reaction (Ivan et al., 2001; Jaakkola et al., 2001; Berra et al., 2003).”
BackgroundThe metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 1×
“Mutations in enzymes coupling the TCA cycle to OXPHOS have been identified (Pollard et al., 2003; Selak et al., 2005; Dang et al., 2009) but account only marginally for the total population of cell lines performing aerobic glycolysis.”
BackgroundWise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
Molecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc882 · Cited by 1,656
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., De Saedeleer, C. J., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,624
Self-citationReflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,516
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
Berra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K., Maxwell, P. H., et al. (2000) · PubMed · Cited by 1,286
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
Hypoxia, DNA repair and genetic instability
Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140
Oncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
Energy metabolism in tumor cells
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, A., & Saavedra, E. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,082
Targeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2817 · Cited by 1,059
Halestrap, A. P., & Meredith, D. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1067-2 · Cited by 1,058
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014 · cited 1×
“In oxygenated cells, proline hydroxylation addresses HIF-1α to the von Hippel–Lindau (VHL) protein complex for poly-ubiquitylation, followed by destruction by the proteasome (Maxwell et al., 1999; Masson et al., 2001; Yu et al., 2001a).”
BackgroundNew Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995
Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R. B., & Hay, N. (2001) · Genes & Development · doi:10.1101/gad.889901 · Cited by 961
The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis
Cardone, R. A., Casavola, V., & Reshkin, S. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1713 · Cited by 897
Ullah, M. S., Davies, A. J., & Halestrap, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511397200 · Cited by 890
Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
Osthus, R. C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D., Lee, L. A., & Dang, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000023200 · Cited by 879
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., & Mueller‐Klieser, W. (2000) · PubMed · Cited by 850
c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation
Wilson, A., Murphy, M. J., Oskarsson, T., Kaloulis, K., Bettess, M. D., Oser, G. M., Pasche, A.-C., Knabenhans, C., MacDonald, H. R., & Trumpp, A. (2004) · Genes & Development · doi:10.1101/gad.313104 · Cited by 823
Végran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2828 · Cited by 816
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
WARBURN, O., & DICKENS, F. (1931) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193107000-00022 · Cited by 808
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
Yu, F., White, S. B., Zhao, Q., & Lee, F. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181341498 · Cited by 796
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., & Yang, X. (2011) · Nature Cell Biology · doi:10.1038/ncb2172 · Cited by 795
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
Hirsilä, M., Koivunen, P., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304982200 · Cited by 794
Wolf, A., Agnihotri, S., Micallef, J., Mukherjee, J., Sabha, N., Cairns, R., Hawkins, C., & Guha, A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101470 · Cited by 789
Chiche, J., Ilc, K., Laferrière, J., Trottier, E., Dayan, F., Mazure, N. M., Brahimi-Horn, M. C., & Pouysségur, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2470 · Cited by 750
Metabolic Modulation of Glioblastoma with Dichloroacetate
Michelakis, E. D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A., Niven, E., Maguire, C., Gammer, T.-L., Mackey, J. R., Fulton, D., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000677 · Cited by 720
Mitochondrial Binding of Hexokinase II Inhibits Bax-induced Cytochrome c Release and Apoptosis
Pastorino, J. G., Shulga, N., & Hoek, J. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109950200 · Cited by 713
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Mazurek, S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.02.005 · Cited by 694
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
Chiche, J., Brahimi‐Horn, M. C., & Pouysségur, J. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00994.x · Cited by 667
Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases
Robey, I. F., Baggett, B. K., Kirkpatrick, N. D., Roe, D. J., Dosescu, J., Sloane, B. F., Hashim, A. I., Morse, D. L., Raghunand, N., Gatenby, R. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-07-5575 · Cited by 661
Kim, J.-W., Gao, P., Liu, Y.-C., Semenza, G. L., & Dang, C. V. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00440-07 · Cited by 658
Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells
Vander Heiden, M. G., Locasale, J. W., Swanson, K. D., Sharfi, H., Heffron, G. J., Amador-Noguez, D., Christofk, H. R., Wagner, G., Rabinowitz, J. D., Asara, J. M., et al. (2010) · Science · doi:10.1126/science.1188015 · Cited by 635
Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis
Li, F., Wang, Y., Zeller, K. I., Potter, J. J., Wonsey, D. R., O'Donnell, K. A., Kim, J.-W., Yustein, J. T., Lee, L. A., & Dang, C. V. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.6225-6234.2005 · Cited by 614
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2010) · Nature · doi:10.1038/nature09132 · Cited by 613
The interplay between MYC and HIF in cancer
Dang, C. V., Kim, J.-W., Gao, P., & Yustein, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2274 · Cited by 613
Structure and function of vacuolar class of ATP-driven proton pumps
Forgac, M. (1989) · Physiological Reviews · doi:10.1152/physrev.1989.69.3.765 · Cited by 593
Brizel, D. M., Schroeder, T., Scher, R. L., Walenta, S., Clough, R. W., Dewhirst, M. W., & Mueller-Klieser, W. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01630-3 · Cited by 586
DIMMER, K.-S., Friedrich, B., Lang, F. J. W., Deitmer, J. W., & Bröer, S. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3500219 · Cited by 577
Bonuccelli, G., Tsirigos, A., Whitaker-Menezes, D., Pavlides, S., Pestell, R. G., Chiavarina, B., Frank, P. G., Flomenberg, N., Howell, A., Martinez-Outschoorn, U. E., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12731 · Cited by 576
Ebert, B. L., Firth, J. D., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29083 · Cited by 575
Markert, C. L., Shaklee, J. B., & Whitt, G. S. (1975) · Science · doi:10.1126/science.1138367 · Cited by 562
Corradetti, M. N., Inoki, K., Bardeesy, N., DePinho, R. A., & Guan, K.-L. (2004) · Genes & Development · doi:10.1101/gad.1199104 · Cited by 560
Pouysségur, J., Sardet, C., Franchi, A., L'Allemain, G., & Paris, S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4833 · Cited by 544
Noguchi, T., Inoue, H., & Tanaka, T. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67091-7 · Cited by 537
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
Chen, J., Xie, J., Jiang, Z., Wang, B., Wang, Y., & Hu, X. (2011) · Oncogene · doi:10.1038/onc.2011.137 · Cited by 512
Som, P., Atkins, H. L., Bandoypadhyay, D., Fowler, J. S., MacGregor, R. R., Matsui, K., Oster, Z. H., Sacker, D. F., Shiue, C. Y., Turner, H., et al. (1980) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198012000-00045 · Cited by 504
Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation
Holness, M. J., & Sugden, M. C. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311143 · Cited by 479
The myc Oncogene: arvelouslomplex
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84004-0 · Cited by 463
Maschek, G., Savaraj, N., Priebe, W., Braunschweiger, P., Hamilton, K., Tidmarsh, G. F., De Young, L. R., & Lampidis, T. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3294 · Cited by 451
Clem, B., Telang, S., Clem, A., Yalcin, A., Meier, J., Simmons, A., Rasku, M. A., Arumugam, S., Dean, W. L., Eaton, J., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0482 · Cited by 432
Lactate: mirror and motor of tumor malignancy
Walenta, S., & Mueller-Klieser, W. F. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.004 · Cited by 428
High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase
Bustamante, E., & Pedersen, P. L. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3735 · Cited by 394
Younes, M., Brown, R. W., Stephenson, M., Gondo, M., & Cagle, P. T. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970915)80:6<1046::aid-cncr6>3.0.co;2-7 · Cited by 381
Metformin: Taking away the candy for cancer?
Jalving, M., Gietema, J. A., Lefrandt, J. D., Jong, S. D., Reyners, A. K. L., Gans, R. O. B., & Vries, E. G. E. D. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.06.012 · Cited by 380
Marsin, A.-S., Bouzin, C., Bertrand, L., & Hue, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205213200 · Cited by 379
for the ‘Tumour and Angiogenesis Research Group’, Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Bougioukas, G., Didilis, V, Gatter, K. C., & Harris, A. L. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601205 · Cited by 377
Glucose Catabolism in Cancer Cells
Mathupala, S. P., Rempel, A., & Pedersen, P. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108181200 · Cited by 373
Minchenko, A., Leshchinsky, I., Opentanova, I., Sang, N., Srinivas, V., Armstead, V., & Caro, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110978200 · Cited by 370
Reshkin, S. J., Bellizzi, A., Caldeira, S., Albarani, V., Malanchi, I., Poignee, M., Alunni‐Fabbroni, M., Casavola, V., & Tommasino, M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0029com · Cited by 366
PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate
Okar, D. A., Lange, A. J., Manzano, À., Navarro-Sabatè, A., Riera, L., & Bartrons, R. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01699-6 · Cited by 357
cDNA Cloning of MCT2, a Second Monocarboxylate Transporter Expressed in Different Cells than MCT1
Garcia, C. K., Brown, M. S., Pathak, R. K., & Goldstein, J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1843 · Cited by 350
Ko, Y. H., Pedersen, P. L., & Geschwind, J. F. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00667-x · Cited by 347
Imamura, K., Ogura, T., Kishimoto, A., Kaminishi, M., & Esumi, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5627 · Cited by 344
Sennoune, S. R., Bakunts, K., Martínez, G. M., Chua-Tuan, J. L., Kebir, Y., Attaya, M. N., & Martínez-Zaguilán, R. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00407.2003 · Cited by 333
Atsumi, T., Chesney, J. A., Metz, C. N., Leng, L., Donnelly, S. C., Makita, Z., Mitchell, R., & Bucala, R. (2002) · PubMed · Cited by 323
Discovery of Novel Antitumor Sulfonamides Targeting G1 Phase of the Cell Cycle
Owa, T., Yoshino, H., Okauchi, T., Yoshimatsu, K., Ozawa, Y., Sugi, N. H., Nagasu, T., Koyanagi, N., & Kitoh, K. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9902638 · Cited by 322
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
Flaig, T. W., Gustafson, D. L., Su, L.-J., Zirrolli, J. A., Crighton, F., Harrison, G. S., Pierson, A. S., Agarwal, R., & Glodé, L. M. (2007) · Investigational New Drugs · doi:10.1007/s10637-006-9019-2 · Cited by 315
Gould, G. W., Thomas, H. M., Jess, T. J., & Bell, G. I. (1991) · Biochemistry · doi:10.1021/bi00235a004 · Cited by 303
Targeting MYC Expression through G-Quadruplexes
Brooks, T. A., & Hurley, L. H. (2010) · Genes & Cancer · doi:10.1177/1947601910377493 · Cited by 301
Stein, M., Lin, H., Jeyamohan, C., Dvorzhinski, D., Gounder, M., Bray, K., Eddy, S., Goodin, S., White, E., & DiPaola, R. S. (2010) · The Prostate · doi:10.1002/pros.21172 · Cited by 291
Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells
Martinez-Zaguilan, R., Lynch, R. M., Martinez, G. M., & Gillies, R. J. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.265.4.c1015 · Cited by 291
Gallagher, S. M., Castorino, J. J., Wang, D., & Philp, N. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3184 · Cited by 288
Tumor Metabolism of Lactate: The Influence and Therapeutic Potential for MCT and CD147 Regulation
Kennedy, K. M., & Dewhirst, M. W. (2010) · Future Oncology · doi:10.2217/fon.09.145 · Cited by 280
Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression
Fang, J. S., Gillies, R. D., & Gatenby, R. A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.011 · Cited by 277
Development of HIF‐1 inhibitors for cancer therapy
Onnis, B., Rapisarda, A., & Melillo, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00876.x · Cited by 268
Abbate, F., Casini, A., Owa, T., Scozzafava, A., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.062 · Cited by 262
Correlation of high lactate levels in head and neck tumors with incidence of metastasis.
Walenta, S., Salameh, A., Lyng, H., Evensen, J. F., Mitze, M., Rofstad, E. K., & Mueller‐Klieser, W. (1997) · Europe PMC (PubMed Central) · Cited by 254
Walenta, S., Schroeder, T., & Mueller-Klieser, W. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364711 · Cited by 248
A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
Greenberger, L. M., Horak, I. D., Filpula, D., Sapra, P., Westergaard, M., Frydenlund, H. F., Albæk, C., Schrøder, H., & Ørum, H. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0510 · Cited by 245
Minchenko, O., Opentanova, I., & Caro, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01179-7 · Cited by 236
Xie, H., Valera, V. A., Merino, M. J., Amato, A. M., Signoretti, S., Linehan, W. M., Sukhatme, V. P., & Seth, P. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1049 · Cited by 233
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
Godsland, I. F. (2010) · Clinical Science · doi:10.1042/cs20090399 · Cited by 231
Paris, S., & Pouysségur, J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90611-3 · Cited by 229
NHE1 promotes invadopodial ECM proteolysis through acidification of the peri‐invadopodial space
Busco, G., Cardone, R. A., Greco, M. R., Bellizzi, A., Colella, M., Antelmi, E., Mancini, M. T., Dell'Aquila, M. E., Casavola, V., Paradiso, A., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-149518 · Cited by 229
Koukourakis, M. I., Giatromanolaki, A., Simopoulos, C., Polychronidis, A., & Sivridis, E. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-2343-7 · Cited by 227
Granchi, C., Roy, S., Giacomelli, C., Macchia, M., Tuccinardi, T., Martinelli, A., Lanza, M., Betti, L., Giannaccini, G., Lucacchini, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101007q · Cited by 227
Nakashima, R. A., Mangan, P. S., Colombini, M., & Pedersen, P. L. (1986) · Biochemistry · doi:10.1021/bi00353a010 · Cited by 222
Zhang, W.-B., Wang, Z., Shu, F., Jin, Y.-H., Liu, H.-Y., Wang, Q.-J., & Yang, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164046 · Cited by 216
Palmieri, D., Fitzgerald, D., Shreeve, S. M., Hua, E., Bronder, J. L., Weil, R. J., Davis, S., Stark, A. M., Merino, M. J., Kurek, R., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0234 · Cited by 214
Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells.
Floridi, A., Paggi, M. G., Marcante, M. L., Silvestrini, B., Caputo, A., & Martino, C. D. (1981) · PubMed · Cited by 211
Hinton, A., Sennoune, S. R., Bond, S., Fang, M., Reuveni, M., Sahagian, G. G., Jay, D., Martinez-Zaguilan, R., & Forgac, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901201200 · Cited by 206
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
Shackelford, D. B., Vasquez, D. S., Corbeil, J., Wu, S., Leblanc, M., Wu, C.-L., Vera, D. R., & Shaw, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900465106 · Cited by 205
Shimoda, L. A., Fallon, M., Pisarcik, S., Wang, J., & Semenza, G. L. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00528.2005 · Cited by 202
V-ATPase inhibitors and implication in cancer treatment
Pérez-Sayáns, M., Somoza-Martín, J. M., Barros-Angueira, F., Rey, J. M. G., & García-García, A. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.08.003 · Cited by 198
Hussain, S. A., Ganesan, R., Reynolds, G., Gross, L., Stevens, A., Pastorek, J., Murray, P. G., Perunovic, B., Anwar, M. S., Billingham, L., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603530 · Cited by 194
Wigfield, S. M., Winter, S. C., Giatromanolaki, A., Taylor, J., Koukourakis, M. L., & Harris, A. L. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604356 · Cited by 191
García-Maceira, P., & Mateo, J. (2009) · Oncogene · doi:10.1038/onc.2008.398 · Cited by 185
GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.
Younes, M., Brown, R. W., Mody, D. R., Fernandez, L., & Laucirica, R. (1995) · PubMed · Cited by 183
Activation of pyruvate dehydrogenase in perfused rat heart by dichloroacetate (Short Communication)
Whitehouse, S., & Randle, P. J. (1973) · Biochemical Journal · doi:10.1042/bj1340651 · Cited by 180
Izumi, H., Takahashi, M., Uramoto, H., Nakayama, Y., Oyama, T., Wang, K., Sasaguri, Y., Nishizawa, S., & Kohno, K. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01908.x · Cited by 179
Pérez de Heredia, F., Wood, I. S., & Trayhurn, P. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0750-3 · Cited by 179
Fructose‐2,6‐bisphosphate and control of carbohydrate metabolism in eukaryotes
Okar, D. A., & Lange, A. J. (1999) · BioFactors · doi:10.1002/biof.5520100101 · Cited by 178
Regulatory Mechanisms in Carbohydrate Metabolism
Wu, R., & Racker, E. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98125-1 · Cited by 177
Boxer, M. B., Jiang, J., Heiden, M. G. V., Shen, M., Skoumbourdis, A. P., Southall, N. T., Veith, H., Leister, W., Austin, C. P., Park, H. W., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901577g · Cited by 165
Leite, T. C., Coelho, R. G., Silva, D. D., Coelho, W. S., Marinho-Carvalho, M. M., & Sola-Penna, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.11.009 · Cited by 165
Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma
Ayala, F. R. R., Rocha, R. M., Carvalho, K. C., Carvalho, A. L., Da Cunha, I. W., Lourenço, S. V., & Soares, F. A. (2010) · Molecules · doi:10.3390/molecules15042374 · Cited by 165
The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase
Pollard, P., Wortham, N., & Tomlinson, I. (2003) · Annals of Medicine · doi:10.1080/07853890310018458 · Cited by 159
Stüwe, L., Müller, M., Fabian, A., Waning, J., Mally, S., Noël, J., Schwab, A., & Stock, C. M. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.145185 · Cited by 156
Ebert, B. L., Gleadle, J., O'ROURKE, J. F., Bartlett, S. M., Poulton, J., & Ratcliffe, P. J. (1996) · Biochemical Journal · doi:10.1042/bj3130809 · Cited by 150
Curi, R., Newsholme, P., & Newsholme, E. A. (1988) · Biochemical Journal · doi:10.1042/bj2500383 · Cited by 147
Thangaraju, M., Carswell, K. N., Prasad, P. D., & Ganapathy, V. (2008) · Biochemical Journal · doi:10.1042/bj20081132 · Cited by 146
SLC5A8 Triggers Tumor Cell Apoptosis through Pyruvate-Dependent Inhibition of Histone Deacetylases
Thangaraju, M., Gopal, E., Martin, P. M., Ananth, S., Smith, S. B., Prasad, P. D., Sterneck, E., & Ganapathy, V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1950 · Cited by 144
Yu, Y., Deck, J. A., Hunsaker, L. A., Deck, L. M., Royer, R. E., Goldberg, E., & Jagt, D. L. V. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00636-0 · Cited by 139
Anticancer drugs that target metabolism: Is dichloroacetate the new paradigm?
Papandreou, I., Golias, T., & Denko, N. C. (2010) · International Journal of Cancer · doi:10.1002/ijc.25728 · Cited by 139
Koukourakis, M. I., Giatromanolaki, A. N., Sivridis, E., Gatter, K. C., Trarbach, T., Folprecht, G., Shi, M. M., Lebwohl, D., Jalava, T., Laurent, D., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2918 · Cited by 133
3-Bromopyruvate: A New Targeted Antiglycolytic Agent and a Promise for Cancer Therapy
Ganapathy‐Kanniappan, S., Vali, M., Kunjithapatham, R., Buijs, M., Syed, L. H., Rao, P. P., Ota, S., Kwak, B. K., Loffroy, R., & Geschwind, J. F. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110791591427 · Cited by 128
Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer
Leiblich, A., Cross, S. S., Catto, J. W. F., Phillips, J. T., Leung, H. Y., Hamdy, F. C., & Rehman, I. (2006) · Oncogene · doi:10.1038/sj.onc.1209262 · Cited by 125
Mouse MCT3 gene is expressed preferentially in retinal pigment and choroid plexus epithelia
Philp, N. J., Yoon, H., & Lombardi, L. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.5.c1319 · Cited by 125
Kinetic properties of the reconstituted glucose transporter from human erythrocytes.
Wheeler, T. J., & Hinkle, P. C. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52485-1 · Cited by 119
Phase II Study of Lonidamine and Diazepam in the Treatment of Recurrent Glioblastoma Multiforme
Oudard, S. M., Carpentier, A., Banu, E., Fauchon, F., Célérier, D., Poupon, M. F., Dutrillaux, B., Andrieu, J. M., & Delattre, J. ‐. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1023756707900 · Cited by 117
Chiche, J., Fur, Y. L., Vilmen, C., Frassineti, F., Daniel, L., Halestrap, A. P., Cozzone, P. J., Pouysségur, J., & Lutz, N. W. (2011) · International Journal of Cancer · doi:10.1002/ijc.26125 · Cited by 116
Nakashima, R. A., Paggi, M. G., Scott, L. J., & Pedersen, P. L. (1988) · PubMed · Cited by 114
Low-field paramagnetic resonance imaging of tumor oxygenation and glycolytic activity in mice
Matsumoto, S., Hyodo, F., Subramanian, S., Devasahayam, N., Munasinghe, J., Hyodo, E., Gadisetti, C., Cook, J. A., Mitchell, J. B., & Krishna, M. C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34928 · Cited by 114
Lin, C.-P., Liu, J., Chow, J., Liu, C.-R., & Liu, H. E. (2006) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3280109424 · Cited by 113
Knoechel, T. R., Tucker, A. D., Robinson, C. M., Phillips, C., Taylor, W. S., Bungay, P. J., Kasten, S. A., Roche, T. E., & Brown, D. G. (2005) · Biochemistry · doi:10.1021/bi051402s · Cited by 111
Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins
Zhan, T., Digel, M., Kuech, E., Stremmel, W., & Füllekrug, J. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22984 · Cited by 109
Reshkin, S. J., Bellizzi, A., Cardone, R. A., Tommasino, M., Casavola, V., & Paradiso, A. (2003) · PubMed · Cited by 102
Minchenko, О. H., Ochiai, A., Opentanova, I., Ogura, T., Minchenko, D. O., Caro, J., Комісаренко, С. В., & Esumi, H. (2005) · Biochimie · doi:10.1016/j.biochi.2005.04.007 · Cited by 102
Koukourakis, M. I., Giatromanolaki, A. N., Winter, S. C., Leek, R., Sivridis, E., & Harris, A. L. (2009) · Oncology · doi:10.1159/000259260 · Cited by 93
Chiang, Y., Chou, C., Hsu, K., Huang, Y., & Shen, M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21277 · Cited by 93
Fantin, V. R., St‐Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.07.011 · Cited by 92
The Catalytic Properties of Human Carbonic Anhydrase IX
Wingo, T. S., Tu, C., Laipis, P. J., & Silverman, D. N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5824 · Cited by 90
Fenske, W., Völker, H., Adam, P., Hahner, S., Johanssen, S., Wortmann, S., Schmidt, M., Morcos, M., Müller–Hermelink, H., Allolio, B., et al. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0211 · Cited by 87
Peng, S., Lai, P., Pan, H., Hsiao, L.-P., & Hsu, H. (2008) · Oncology Reports · doi:10.3892/or.19.4.1045 · Cited by 85
Talbot, D. C., von Pawel, J., Cattell, E., Yule, S. M., Johnston, C., Zandvliet, A. S., Huitema, A. D. R., Norbury, C. J., Ellis, P., Bosquée, L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0249 · Cited by 83
Maidorn, R., Cragoe, E. J., & Tannock, I. F. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.56 · Cited by 78
Lactate Transporter Defect: A New Disease of Muscle
Fishbein, W. N. (1986) · Science · doi:10.1126/science.3775384 · Cited by 76
Battke, C., Kremmer, E., Mysliwietz, J., Gondi, G., Dumitru, C. A., Brandau, S., Lang, S., Vullo, D., Supuran, C. T., & Zeidler, R. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0980-z · Cited by 75
Martı́n-Castillo, B., Dorca, J., Vázquez‐Martín, A., Oliveras‐Ferraros, C., López‐Bonet, E., García, M., del Barco, S., & Menéndez, J. A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp494 · Cited by 64
Keßler, R., Bleichert, F., Warnke, J., & Eschrich, K. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9471-7 · Cited by 62
Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent
Dell’Antone, P. (2009) · Medicinal Chemistry · doi:10.2174/157340609790170551 · Cited by 59
Lyshchik, A. P., Higashi, T., Hara, T., Nakamoto, Y., Fujimoto, K., Doi, R., Imamura, M., Saga, T., & Togashi, K. (2007) · Cancer Investigation · doi:10.1080/07357900701208931 · Cited by 59
Regulation of Pyruvate Kinase M Gene Expression
Yamada, K., & Noguchi, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0228 · Cited by 58
Glut3 Expression in Biopsy Specimens of Laryngeal Carcinoma Is Associated With Poor Survival
Baer, S., Casaubon, L., Schwartz, M. R., Marcogliese, A. N., & Younes, M. (2002) · The Laryngoscope · doi:10.1097/00005537-200202000-00034 · Cited by 55
Small-Molecule Modulators of c-Myc/Max and Max/Max Interactions
Berg, T. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_90 · Cited by 54
3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines
Qin, J.-Z., Xin, H., & Nickoloff, B. J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.126 · Cited by 52
Bueno, V., Binet, I., Steger, U., Bundick, R. V., Ferguson, D., Murray, C. M., Donald, D. K., & Wood, K. J. (2007) · Transplantation · doi:10.1097/01.tp.0000287543.91765.41 · Cited by 51
Rho, M.-S., Kim, J., Jee, C. D., Lee, Y. M., Lee, H. E., Kim, M. A., Lee, H. S., & Kim, W. H. (2007) · PubMed · Cited by 51
Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX
Murri-Plesko, M. T., Hulíková, A., Oosterwijk, E., Scott, A. M., Zortea, A., Harris, A. L., Ritter, G., Old, L. J., Bauer, S., Swietach, P., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.063 · Cited by 47
Xu, C., Lo, A. S., Yammanuru, A., Tallarico, A. S. C., Brady, K. W., Murakami, A., Barteneva, N. S., Zhu, Q. K., & Marasco, W. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009625 · Cited by 47
Reinacher, M., & EIGENBRODT, E. (1981) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02892557 · Cited by 46
Mo, X., Chen, Q., Li, X., Zheng, M., Ke, D., Deng, W., Li, G., Jiang, J. F., Wu, Z., Wang, L., et al. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.12.004 · Cited by 44
Wolf, A., Agnihotri, S., Micallef, J., et al. (2011) · The Journal of Cell Biology · doi:10.1083/jcb1922oia1 · Cited by 44
Metformin, diet and breast cancer: An avenue for chemoprevention
Muti, P. C., Berrino, F., Krogh, V., Villarini, A., Barba, M., Strano, S., & Blandino, G. (2009) · Cell Cycle · doi:10.4161/cc.8.16.9226 · Cited by 35
Tal, M., Thorens, B., Surana, M., Fleischer, N., Lodish, H. F., Hanahan, D., & Efrat, S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.422-432.1992 · Cited by 34
Lim, J.-H., Park, J., Kim, S. J., Kim, M.-S., Park, S.-K., Johnson, R. S., & Chun, Y. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030296 · Cited by 28
Yang, X., Wang, D., Dong, W., Song, Z., & Dou, K. (2009) · Medical Oncology · doi:10.1007/s12032-009-9343-4 · Cited by 28
Development of small molecule carbonic anhydrase IX inhibitors
Supuran, C. T. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07648.x · Cited by 23
Diabetes mellitus, medications for type 2 diabetes mellitus, and cancer risk
Vecchia, C. L. (2011) · Metabolism · doi:10.1016/j.metabol.2011.03.011 · Cited by 21
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(19980701)83:1 · Cited by 3
Cited by
Emerging regulation and functions of autophagy
Boya, P., Reggiori, F., & Codogno, P. (2013) · Nature Cell Biology · doi:10.1038/ncb2788 · Cited by 1,216
On the Origin of Cancer Metastasis
Seyfried, T. N., & Huysentruyt, L. C. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.40 · Cited by 1,196
Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
ZHENG, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.928 · Cited by 963
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Schulze, A., & Harris, A. L. (2012) · Nature · doi:10.1038/nature11706 · Cited by 929
Lu, J., Tan, M., & Cai, Q. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.04.001 · Cited by 795
Metadata
- Authors
- Porporato, P. E., Dhup, S., Dadhich, R. K., Copetti, T., & Sonveaux, P.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2011
- Volume
- 2
- Pages
- 49-49
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2020993937
- Cited by
- 425
- References
- 194
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.